Skip to main content

A 3242 — New Jersey

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Passed one chamber 222 session General Assembly

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • A 3242 is a bill in the New Jersey General Assembly, 222 session, introduced January 13, 2026.
  • Sponsored by Hutchison, Dan, Donlon, Margie, M.D., and Simmons, Heather, with 5 cosponsors.
  • Current status: passed one chamber.
  • Most recent action (October 29, 2026): Passed by the Assembly (72-0-5).
  • 3 recorded votes; the most recent, on October 29, 2026, passed 72-0.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Hutchison, Dan, Donlon, Margie, M.D., Simmons, Heather

Cosponsors (5): Miller, Cody D., Bagolie, Rosaura, Reynolds-Jackson, Verlina, Sampson, William B., IV, Venezia, Michael

History

  1. Introduced, completed
  2. Passed General Assembly, completed
  3. Passed Senate, in progress
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. General Assembly Introduced, Referred to Assembly Financial Institutions and Insurance Committee Milestone
  2. General Assembly Reported out of Asm. Comm. with Amendments, and Referred to Assembly Appropriations Committee

    Reported out of Assembly committee with amendments: 13 yes 0 no, 1 other Passed, 100% yes

  3. General Assembly Reported out of Assembly Committee, 2nd Reading

    Reported favorably out of committee: 12 yes 0 no, 3 other Passed, 100% yes

  4. General Assembly Passed by the Assembly (72-0-5) Milestone Latest

    3RDG FINAL PASSAGE: 72 yes 0 no, 8 other Passed, 100% yes

Source: Open States. Last checked November 9, 2026. How we keep this accurate ›